Literature DB >> 31907789

Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction.

Mark D Sullivan1, Denise Boudreau2, Laura Ichikawa2, David Cronkite2, Ladia Albertson-Junkans2, Gladys Salgado2, Michael VonKorff2, David S Carrell2.   

Abstract

BACKGROUND: Primary care providers prescribe most long-term opioid therapy and are increasingly asked to taper the opioid doses of these patients to safer levels. A recent systematic review suggests that multiple interventions may facilitate opioid taper, but many of these are not feasible within the usual primary care practice.
OBJECTIVE: To determine if opioid taper plans documented by primary care providers in the electronic health record are associated with significant and sustained opioid dose reductions among patients on long-term opioid therapy.
DESIGN: A nested case-control design was used to compare cases (patients with a sustained opioid taper defined as average daily opioid dose of ≤ 30 mg morphine equivalent (MME) or a 50% reduction in MME) to controls (patients matched to cases on year and quarter of cohort entry, sex, and age group, who had not achieved a sustained taper). Each case was matched with four controls. PARTICIPANTS: Two thousand four hundred nine patients receiving a ≥ 60-day supply of opioids with an average daily dose of ≥ 50 MME during 2011-2015. MAIN MEASURES: Opioid taper plans documented in prescription instructions or clinical notes within the electronic health record identified through natural language processing; opioid dosing, patient characteristics, and taper plan components also abstracted from the electronic health record. KEY
RESULTS: Primary care taper plans were associated with an increased likelihood of sustained opioid taper after adjusting for all patient covariates and near peak dose (OR = 3.63 [95% CI 2.96-4.46], p < 0.0001). Both taper plans in prescription instructions (OR = 4.03 [95% CI 3.19-5.09], p < 0.0001) and in clinical notes (OR = 2.82 [95% CI 2.00-3.99], p < 0.0001) were associated with sustained taper.
CONCLUSIONS: These results suggest that planning for opioid taper during primary care visits may facilitate significant and sustained opioid dose reduction.

Entities:  

Keywords:  case-control study; dose reduction; long-term opioid therapy; natural language processing; opioid discontinuation

Mesh:

Substances:

Year:  2020        PMID: 31907789      PMCID: PMC7080895          DOI: 10.1007/s11606-019-05445-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  3 in total

1.  International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering.

Authors:  Beth D Darnall; David Juurlink; Robert D Kerns; Sean Mackey; Brent Van Dorsten; Keith Humphreys; Julio A Gonzalez-Sotomayor; Andrea Furlan; Adam J Gordon; Debra B Gordon; Diane E Hoffman; Joel Katz; Stefan G Kertesz; Sally Satel; Richard A Lawhern; Kate M Nicholson; Rosemary C Polomano; Owen D Williamson; Heath McAnally; Ming-Chih Kao; Stephan Schug; Robert Twillman; Terri A Lewis; Richard L Stieg; Kate Lorig; Theresa Mallick-Searle; Robert W West; Sarah Gray; Steven R Ariens; Jennifer Sharpe Potter; Penney Cowan; Chad D Kollas; Danial Laird; Barby Ingle; J Julian Grove; Marian Wilson; Kashelle Lockman; Fiona Hodson; Carol S Palackdharry; Roger B Fillingim; Jeffrey Fudin; Jennifer Barnhouse; Ajay Manhapra; Steven R Henson; Bruce Singer; Marie Ljosenvoor; Marlisa Griffith; Jason N Doctor; Kimeron Hardin; Cathleen London; Jon Mankowski; Andrea Anderson; Linda Ellsworth; Lisa Davis Budzinski; Becky Brandt; Greg Hartley; Debbie Nickels Heck; Mark J Zobrosky; Celeste Cheek; Megan Wilson; Cynthia E Laux; Geralyn Datz; Justin Dunaway; Eileen Schonfeld; Melissa Cady; Thérèse LeDantec-Boswell; Meredith Craigie; John Sturgeon; Pamela Flood; Melita Giummarra; Jessica Whelan; Beverly E Thorn; Richard L Martin; Michael E Schatman; Maurice D Gregory; Joshua Kirz; Patti Robinson; James G Marx; Jessica R Stewart; Phillip S Keck; Scott E Hadland; Jennifer L Murphy; Mark A Lumley; Kathleen S Brown; Michael S Leong; Mechele Fillman; James W Broatch; Aaron Perez; Kristine Watford; Kari Kruska; Dokyoung Sophia You; Stacy Ogbeide; Amy Kukucka; Susan Lawson; James B Ray; T Wade Martin; James B Lakehomer; Anne Burke; Robert I Cohen; Peter Grinspoon; Marc S Rubenstein; Stephani Sutherland; Kristie Walters; Travis Lovejoy
Journal:  Pain Med       Date:  2019-03-01       Impact factor: 3.750

2.  Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans.

Authors:  Eric J Hawkins; Carol A Malte; Hildi J Hagedorn; Douglas Berger; Anissa Frank; Aline Lott; Carol E Achtmeyer; Anthony J Mariano; Andrew J Saxon
Journal:  Pain Med       Date:  2017-03-01       Impact factor: 3.750

3.  Discrepancies Between Perceived Benefit of Opioids and Self-Reported Patient Outcomes.

Authors:  Jenna Goesling; Stephanie E Moser; Lewei A Lin; Afton L Hassett; Ronald A Wasserman; Chad M Brummett
Journal:  Pain Med       Date:  2018-02-01       Impact factor: 3.750

  3 in total
  3 in total

1.  Capsule Commentary on Sullivan et al., Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction.

Authors:  Jessica A Chen
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

Review 2.  Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review.

Authors:  Amy Coe; Catherine Kaylor-Hughes; Susan Fletcher; Elizabeth Murray; Jane Gunn
Journal:  BMJ Open       Date:  2021-09-06       Impact factor: 3.006

Review 3.  The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology.

Authors:  Robert J Romanelli; Naomi R M Schwartz; William G Dixon; Carla Rodriguez-Watson; Brian C Sauer; Dawn Albright; Zachary A Marcum
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-07-28       Impact factor: 2.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.